CoChat

A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression

Open access
Reinares, María, Rosa, Adriane R., Franco, Carolina, Goikolea, José Manuel, Fountoulakis, Kostas, Siamouli, Melina, Gonda, Xenia, Frangou, Sophia, Vieta, Eduard · 2013 · International Journal of Neuropsychopharmacology
Cited by 56

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Despite the high morbidity and mortality associated with bipolar depression, the optimal treatment for this phase is still a matter of debate. The aim of the current review was to provide updated evidence about the efficacy and tolerability of anticonvulsants in the treatment of acute bipolar depression. A comprehensive review of randomized controlled trials (RCTs) evaluating the use of anticonvulsants for the treatment of acute bipolar depression up to June 2011 was conducted by means of the PubMed-Medline database. Eligibility criteria included active comparator-controlled or placebo-controlled randomized studies involving monotherapy or combination therapy. A total of 18 RCTs fulfilled the inclusion criteria. Studies supported the efficacy of divalproex as monotherapy in acute bipolar depression but small sample size was a common methodological limitation. Findings were inconclusive for lamotrigine and carbamazepine although overall lamotrigine may have a beneficial but modest effect. Negative results were found for levetiracetam and gabapentin but the evidence base on these agents is scant. All anticonvulsants were generally well tolerated. No double-blind RCTs were found for the use of other anticonvulsants such as oxcarbazepine, licarbazepine, zonisamide, retigabine, pregabalin, tiagabine, felbamate and vigabatrine in the acute treatment of bipolar depression. To sum up, taking into consideration the efficacy and tolerability profiles of anticonvulsants, current evidence supports the use of divalproex and lamotrigine in the treatment of acute bipolar depression. However, available data for most other anticonvulsants are inconclusive and further RCTs with larger sample sizes are needed before drawing firm conclusions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145712000491

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 56

Metadata

Authors
Reinares, M., Rosa, A. R., Franco, C., Goikolea, J. M., Fountoulakis, K., Siamouli, M., Gonda, X., Frangou, S., & Vieta, E.
Venue
International Journal of Neuropsychopharmacology
Published
2012-05-10
Volume
16
Issue
2
Pages
485-496
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2104574759
Cited by
56
References
13
FWCI
1.16
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression. https://app.cochat.ai/papers/10.1017/s1461145712000491
The paper
Reinares, M., Rosa, A. R., Franco, C., Goikolea, J. M., Fountoulakis, K., Siamouli, M., Gonda, X., Frangou, S., & Vieta, E. (2013). A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression. International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145712000491

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.